Preclinical Research

Collagen Antibody-induced Arthritis

Inflammation/Autoimmune DIseases

Collagen Antibody-induced Arthritis (CAIA)

The Collagen Antibody Induced Arthritis (CAIA) model is a rapid and synchronized alternative to the Collagen Induced Arthritis model. A cocktail of arthritogenic monoclonal antibodies to CII combined with a boost of LPS is used to induce arthritis. These arthritis inducing antibodies recognize a wide range of epitopes on the CII molecule and thereby allow formation of large immune complexes on the cartilage. Since these pre-formed antibodies are administered, the initial phase of the immune response involving T and B cell interaction is not present. This makes the model far more rapid, with onset within 48 hours of LPS boost and a total duration of as little as 10 days.
 

CAIA Study Details:

  • Length: 10-18 days
  • Dosing Paradigms: Prophylactic (developing or semi-established)
  • Dosing routes: PO, IP, SC, IV, Infusion pump
  • Controls: Dexamethasone, Enbrel
  • Assessments: Arthritis Score, Hind paw thickness, Body weight

 

Optional Assessments:

  • Circulating or tissue level Biomarker analysis (protein or mRNA)
  • Histological/IHC assessment of joints
  • PK blood collections
  • Cell populations in the spleen/lymph node by FACS

 

SPECIES AVAILABLE

  • mouse CAIA

 

Request Study Proposal
collagen antibody-induced arthritis (CAIA)

 


CONTACT US:

1-888-876-3246
+41-44 986-2628
email us